Trending
Most Popular
War, Oil, Repeat: Why Markets Treat The Iran Crisis Like A Sequel With The Same Ending -( $DIA $QQQ $SPY $VIX )
Wall Street ended yet another session staring at the same old geopolitical headline—“war with Iran not…
by John F. Heerdink, Jr. 17 hours ago
April 1, 2026 – Stocks Launch April Rally on Hopes of Iran War Off‑Ramp and Softer Oil – ( $EPRX $GOVX $MODD $MTWO $NOK $NVDA $SER $SOAR $TSLA Rise!)
The stock market extended its relief rally on Wednesday, April 1, 2026, as Wall Street bet…
by John F. Heerdink, Jr. 22 hours ago
Agriculture & Energy
War, Oil, Repeat: Why Markets Treat The Iran Crisis Like A Sequel With The Same Ending -( $DIA $QQQ $SPY $VIX )
Wall Street ended yet another session staring at the same old geopolitical headline—“war with Iran not…
by John F. Heerdink, Jr. 17 hours ago
The San Francisco Consensus: How AGI Turned a Six‑Year Plan into a Weekend Project -( $GOOG $NVDA )
Artificial superintelligence, according to today’s San Francisco skyline of optimists, is no longer a distant sci‑fi…
by John F. Heerdink, Jr. March 23, 2026
Saudi Petrodollars Meet Pixel Warriors: Inside Savvy Games’ $6 Billion Moonton Power-Up
ByteDance’s decision to sell Moonton, the studio behind “Mobile Legends: Bang Bang,” to Saudi Arabia’s Savvy…
by John F. Heerdink, Jr. March 23, 2026
Biotech & Healthcare
Acquired Taste: Why Big Pharma Can’t Stop Snacking on Venture‑Backed Biotechs -( $IBB $MRK $OTSKY $NVS $TERN $XBI )
Big Pharma spent the week shopping again, snapping up a fresh crop of biotech and pharmaceutical…
by John F. Heerdink, Jr. 15 hours ago
Register Now: Tribe Public’s 30-Minute Deep Dive on Making EoE a Once‑a‑Year Appointment -( $EPRX $SNY $IBB $XBI )
Vista Partners is passing along a timely heads-up from our sister organization, Tribe Public www.TribePublic.com, which…
by John F. Heerdink, Jr. 2 days ago
When Half-Lives Matter More Than Deadlines: Inside NAYA’s Radiopharma Supply Chain- ( $IBB $XBI )
NAYA Therapeutics is quietly building what many cancer drug developers say they want but few can…
by John F. Heerdink, Jr. 3 days ago
Consumer Goods & Trends
Ducati’s $165,000 Superleggera V4 Didn’t Just Sell Out. It Vanished To Beat the Market – ( $VWAGY )
On Wall Street, a hot IPO that prices above the range and breaks syndicate in minutes…
by John F. Heerdink, Jr. 3 days ago
Olaplex’s Golden Strands: Henkel’s 1.4B Buyout Deal Seems To Prove Science May Style Fortunes On Occasion -( $OLPX $SPY )
Olaplex (NASDAQ: OLPX), the science-driven haircare innovator, has captured Wall Street's attention with its bond-building technology…
by John F. Heerdink, Jr. March 26, 2026
Billion Clicks and Counting: Inside the Spider-Man Trailer That Made “Viral” Look Small -( $DIS $SONY )
Spider-Man just did what Wall Street dreams of: turned a teaser into a trillion‑eyeball asset class,…
by John F. Heerdink, Jr. March 25, 2026
Financials & Fintech
Please Hold (Never): How Shift4, Maple, Nokia and Nvidia Turn Missed Calls Into Money -( $FOUR $NOK $NVDA )
Shift4 (FOUR) is quietly stitching together a commerce empire, and its latest moves in AI phone…
by John F. Heerdink, Jr. March 24, 2026
Home Sales Near 30-Year Lows—But Buyers Are Quietly Plotting a Comeback? -( $SPY $DIA $HD )
US existing-home sales may be slumping toward historic lows, but the housing market is quietly laying…
by John F. Heerdink, Jr. March 19, 2026
When Bangles Meet Bankers: Inside India’s Glittering Gold-Loan Boom -( $GLD )
India’s gold-backed lending boom is turning family heirlooms into the country’s most hardworking asset class, as…
by John F. Heerdink, Jr. March 19, 2026
Investing & Inspiration
Mission Critical: Inside the M2i Global Season One Series Redefining America’s Critical Minerals Strategy -( $MTWO $SOAR )
Season One of this series, hosted by Major General (Ret) Alberto “Al” Rosende, President & CEO…
by John F. Heerdink, Jr. 6 minutes ago
Acquired Taste: Why Big Pharma Can’t Stop Snacking on Venture‑Backed Biotechs -( $IBB $MRK $OTSKY $NVS $TERN $XBI )
Big Pharma spent the week shopping again, snapping up a fresh crop of biotech and pharmaceutical…
by John F. Heerdink, Jr. 15 hours ago
War, Oil, Repeat: Why Markets Treat The Iran Crisis Like A Sequel With The Same Ending -( $DIA $QQQ $SPY $VIX )
Wall Street ended yet another session staring at the same old geopolitical headline—“war with Iran not…
by John F. Heerdink, Jr. 17 hours ago
Materials & Natural Resources
Mission Critical: Inside the M2i Global Season One Series Redefining America’s Critical Minerals Strategy -( $MTWO $SOAR )
Season One of this series, hosted by Major General (Ret) Alberto “Al” Rosende, President & CEO…
by John F. Heerdink, Jr. 6 minutes ago
Solar, EVs, AI… And Silver: The One Metal Your ‘Modern Portfolio’ Forgot To Invite -( $SIL )
Gold may still own the vault, but in 2026 silver is quietly applying for a corner…
by John F. Heerdink, Jr. March 24, 2026
When Bangles Meet Bankers: Inside India’s Glittering Gold-Loan Boom -( $GLD )
India’s gold-backed lending boom is turning family heirlooms into the country’s most hardworking asset class, as…
by John F. Heerdink, Jr. March 19, 2026
Technology & Beyond
SpaceX’s ‘Quiet’ Countdown to Wall Street: A ‘Confidential’ IPO With Cosmic Ambition -( $TSLA )
There are open secrets on Wall Street, and then there is SpaceX’s long‑anticipated march toward the…
by John F. Heerdink, Jr. 24 hours ago
Please Hold (Never): How Shift4, Maple, Nokia and Nvidia Turn Missed Calls Into Money -( $FOUR $NOK $NVDA )
Shift4 (FOUR) is quietly stitching together a commerce empire, and its latest moves in AI phone…
by John F. Heerdink, Jr. March 24, 2026
SK hynix, ASML and the $8 Billion Lithography Love Story Powering the Next AI Boom -( $ASML )
SK hynix just wrote an enormous check to the future of AI memory, agreeing to spend…
by John F. Heerdink, Jr. March 24, 2026
Latest News
Mission Critical: Inside the M2i Global Season One Series Redefining America’s Critical Minerals Strategy -( $MTWO $SOAR )
Season One of this series, hosted by Major General (Ret) Alberto “Al” Rosende, President & CEO…
by John F. Heerdink, Jr. 6 minutes ago
Acquired Taste: Why Big Pharma Can’t Stop Snacking on Venture‑Backed Biotechs -( $IBB $MRK $OTSKY $NVS $TERN $XBI )
Big Pharma spent the week shopping again, snapping up a fresh crop of biotech and pharmaceutical…
by John F. Heerdink, Jr. 15 hours ago
War, Oil, Repeat: Why Markets Treat The Iran Crisis Like A Sequel With The Same Ending -( $DIA $QQQ $SPY $VIX )
Wall Street ended yet another session staring at the same old geopolitical headline—“war with Iran not…
by John F. Heerdink, Jr. 17 hours ago
Must-Watch Videos
Most Read
Featured
Mission Critical: Inside the M2i Global Season One Series Redefining America’s Critical Minerals Strategy -( $MTWO $SOAR )
Season One of this series, hosted by Major General (Ret) Alberto “Al” Rosende, President & CEO…
by John F. Heerdink, Jr. 6 minutes ago
Acquired Taste: Why Big Pharma Can’t Stop Snacking on Venture‑Backed Biotechs -( $IBB $MRK $OTSKY $NVS $TERN $XBI )
Big Pharma spent the week shopping again, snapping up a fresh crop of biotech and pharmaceutical…
by John F. Heerdink, Jr. 15 hours ago
Amazon’s Amazing Theatrical Expansion – $AMZN $SPY
Amazon has unveiled ambitious plans to significantly increase its theatrical movie releases starting in 2025, aiming…
by John F. Heerdink, Jr. April 3, 2025
Lawrence Summers Warns of Economic Storm Clouds Ahead – $SPY $QQQ $DIA $VIX
Former Treasury Secretary Lawrence Summers has delivered a sobering outlook for the U.S. economy, suggesting that…
by John F. Heerdink, Jr. April 8, 2025
